Eli Lilly’s Alzheimer’s drug permitted by FDA: What to know TODAYFDA approves new Alzheimer’s remedy choice Fox NewsFDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’s The New York TimesLilly’s Kisunla™ (donanemab-azbt) Accepted by the FDA for the Therapy of Early Symptomatic Alzheimer’s Illness | Eli Lilly and Firm Buyers | Eli Lilly and CompanyFDA approves Eli Lilly’s Alzheimer’s drug that slows reminiscence decline NBC Information